Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

ARK's Cathie Wood Dumps More Twitter Stock, Buys $20M in Fate Therapeutics Stock

Published 12/08/2022, 14:29
Updated 12/08/2022, 15:10
© Reuters.  ARK's Cathie Wood Dumps More Twitter Stock, Buys $20M in Fate Therapeutics Stock

Cathie Wood-led Ark Investment Management has bought 628,060 shares of clinical-stage biopharmaceutical company Fate Therapeutics Inc. (NASDAQ: FATE) through two of the firm’s exchange-traded funds (ETF) valued at over $20 million based on Thursday’s closing price.

Fate Therapeutics is the 21st largest holding in Ark Innovation ETF (NYSE: ARKK), the firm’s flagship fund, with a weight of 2.08%. The fund holds over 6.5 million shares of the firm valued at over $211 million, according to its website.

Also Read: Alibaba (NYSE:BABA) Holds It Together, EV Stocks Shine As Wider Hang Seng Falls: Key Events Driving Hong Kong Stocks Today

The stock has gained over 9% in a month. Fate Therapeutics recently reported revenues of $18.5 million for the second quarter of 2022. Its earnings per share stood at $-0.79 against the estimate of $-0.82 according to Benzinga Pro.

Twitter share sale: Ark Investment Management has sold 1,451 shares of Twitter Inc (NYSE: NYSE:TWTR) valued at over $63,000 via two of its funds.

Other Major Trades: Cathie Wood also bought 100,852 shares of Teladoc Health Inc (NYSE: TDOC) valued at over $3.8 million via four of the firm’s funds. Wood sold over 1.3 million shares of Compugen Ltd. (NASDAQ: CGEN) valued at over $1.9 million through two of the firm’s funds.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.